GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (NAS:CDXC) » Definitions » Shiller PE Ratio

ChromaDex (ChromaDex) Shiller PE Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is ChromaDex Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ChromaDex Shiller PE Ratio Historical Data

The historical data trend for ChromaDex's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromaDex Shiller PE Ratio Chart

ChromaDex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ChromaDex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ChromaDex's Shiller PE Ratio

For the Biotechnology subindustry, ChromaDex's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChromaDex's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChromaDex's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ChromaDex's Shiller PE Ratio falls into.



ChromaDex Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ChromaDex's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, ChromaDex's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

ChromaDex Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.060 99.695 -0.078
201406 -0.060 100.560 -0.077
201409 -0.030 100.428 -0.039
201412 -0.030 99.070 -0.039
201503 -0.030 99.621 -0.039
201506 -0.010 100.684 -0.013
201509 0.000 100.392 0.000
201512 -0.040 99.792 -0.052
201603 0.010 100.470 0.013
201606 -0.002 101.688 -0.003
201609 -0.030 101.861 -0.038
201612 -0.060 101.863 -0.076
201703 -0.050 102.862 -0.063
201706 -0.070 103.349 -0.088
201709 0.040 104.136 0.050
201712 -0.170 104.011 -0.212
201803 -0.150 105.290 -0.184
201806 -0.150 106.317 -0.183
201809 -0.160 106.507 -0.194
201812 -0.150 105.998 -0.183
201903 -0.150 107.251 -0.181
201906 -0.140 108.070 -0.168
201909 -0.120 108.329 -0.143
201912 -0.150 108.420 -0.179
202003 -0.100 108.902 -0.119
202006 -0.060 108.767 -0.071
202009 -0.070 109.815 -0.082
202012 -0.100 109.897 -0.118
202103 -0.120 111.754 -0.139
202106 -0.080 114.631 -0.090
202109 -0.130 115.734 -0.145
202112 -0.080 117.630 -0.088
202203 -0.110 121.301 -0.117
202206 -0.090 125.017 -0.093
202209 -0.010 125.227 -0.010
202212 -0.020 125.222 -0.021
202303 -0.030 127.348 -0.030
202306 -0.030 128.729 -0.030
202309 -0.010 129.860 -0.010
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ChromaDex  (NAS:CDXC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ChromaDex Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of ChromaDex's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ChromaDex (ChromaDex) Business Description

Traded in Other Exchanges
Address
10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.
Executives
Brianna Gerber officer: SVP Finance / Interim CFO C/O CHROMADEX, INC., 1735 FLIGHT WAY, SUITE 200, TUSTIN CA 92782
Champion River Ventures Ltd 10 percent owner C/O 7F, CHEUNG KONG CENTER, 2 QUEEN'S ROAD, CENTRAL K3 00000
Jaksch Frank L Jr director, 10 percent owner, officer: Chief Executive Officer 10005 MUIRLANDS BOULEVARD, SUITE G FIRST FLOOR, IRVINE CA 92618
Robert N Fried director 100 NORTH CRESCENT DRIVE, BEVERLY HILLS CA 90210
Steven D Rubin director OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Li Ka Shing 10 percent owner 79 DEEP WATER BAY ROAD, HONG KONG F4 00000
Chau Hoi Shuen Solina Holly 10 percent owner SUITES PT. 2909 & 2910, HARBOUR CENTRE, 25 HARBOUR ROAD, WANCHAI K3 999077
Hamed Shahbazi director C/O CHROMADEX, INC., 1735 FLIGHT WAY, SUITE 200, TUSTIN CA 92782
Ann Cohen director C/O CHROMADEX CORPORATION, 10900 WILSHIRE BLVD. STE 600, LOS ANGELES CA 90024
Kristin Patrick director 3329 CAY DRIVE, SHERMAN OAKS CA 91423
Ng Wang Yu Gary director ROOM 1709 HARBOUR CENTER, 25 HARBOUR ROAD, WANCHAI K3 -
Caroline S Levy director 2424 N FEDERAL HIGHWAY, SUITE 208, BOCA RATON FL 33431
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Lisa Hatton Harrington officer: General Counsel 53 SEA TERRACE, NEWPORT COAST CA 92657
Kevin M Farr officer: Chief Financial Officer MATTEL, INC., 333 CONTINENTAL BLVD, M1-1518, EL SEGUNDO CA 90245

ChromaDex (ChromaDex) Headlines

From GuruFocus

A Letter from the ChromaDex Chief Executive Officer

By Business Wire Business Wire 02-21-2023